Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

McGill University

$25,000.00

Exploration of new chemicals to enable rapid functionalization of pharmaceuticals**

FY 2018-19

Summary
Paraza Pharma intends to diversify pharmaceutical molecules/intermediates for rapid Structure-Activity-Relationship (SAR) studies. However, the current methodologies lacks the compatibility of many functional groups which usually exist in advance pharmaceutical intermediate. Furthermore, many pharmaceutical interesting fragments requires multiple steps to be introduced into the pharmaceutical intermediates. The proposed project will address this problem using novel alkylating reactions recently discovered in Professor Chao-Jun Li's laboratory. The project will pursue new chemical matters which will allow the functionalization of advance pharmaceuticals in one step. The research will be focusing on optimizing reaction conditions to allow chemo-selective and functional group tolerable transformation possible. *The success of this proposed project will be a significant advancement in pharmaceutical industry research and development.*
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
537314-2018
Name nom
Li, ChaoJun
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
1
Nb partie
1
Application title
Exploration of new chemicals to enable rapid functionalization of pharmaceuticals**
Keyword
NSERC
Application summary
Paraza Pharma intends to diversify pharmaceutical molecules/intermediates for rapid Structure-Activity-Relationship (SAR) studies. However, the current methodologies lacks the compatibility of many functional groups which usually exist in advance pharmaceutical intermediate. Furthermore, many pharmaceutical interesting fragments requires multiple steps to be introduced into the pharmaceutical intermediates. The proposed project will address this problem using novel alkylating reactions recently discovered in Professor Chao-Jun Li's laboratory. The project will pursue new chemical matters which will allow the functionalization of advance pharmaceuticals in one step. The research will be focusing on optimizing reaction conditions to allow chemo-selective and functional group tolerable transformation possible. *The success of this proposed project will be a significant advancement in pharmaceutical industry research and development.*